|
Lung Cancer Europe survey: Access to novel drugs |
General
The LuCE (Lung Cancer Europe) is the voice of lung cancer patients, their families and survivors at the European level. Together with lung cancer researchers, LuCE created a survey to study the access to novel drugs in Europe.
Please respond to this ten-minute survey on the aspects of policy and practice in your country. The survey will provide LuCE with valuable data on further actions needed to improve access to care and reduce disparities in Europe.
Thank you for your participation!